Beximco launches four new drugs
Leading drug manufacturer in Bangladesh Beximco Pharmaceuticals Ltd (BPL) Tuesday launched four new drugs for the treatment of Parkinson's disease, pain and inflammation, Psoriasis and Herpes viruses, a statement said.
bdnews24.com News Service
bdnews24.com
Published :
06 Feb 2006, 06:00 PM
Updated :
17 Aug 2022, 05:47 PM
Dhaka, Feb 7 (BDNEWS) - Leading drug manufacturer in Bangladesh Beximco Pharmaceuticals Ltd (BPL) Tuesday launched four new drugs for the treatment of Parkinson's disease, pain and inflammation, Psoriasis and Herpes viruses, a statement said.
The drugs are Repitol® for Parkinson's disease, Dexifen® for pain management, Ovalac® for the treatment of Herpes viruses and Soritene® ointment for Psoriasis, a skin disease, the statement said.
On the launching of Repitol® , Nazmul Hassan, Chief Executive Officer of the company said there are significant number of patients in Bangladesh having Parkinsonism, and from now on the Beximco Pharma drug, Repitol®, will be available in two doses in the local market.
Repitol® 0.25 mg tablet is available for Tk. 2 each and Repitol® 2 mg tablet for Tk. 10 each. Both the doses are available in 30's pack.
Repitol® tablets containing Ropinirole, are efficacious when used as monotherapy in Parkinson's disease and the United States Food and Drug Administration (USFDA) has also approved the drug for Restless Legs Syndrome.
Another BPL drug Dexifen® provides strong efficacy against pain and inflammation. Dexifen® is available in 3 different doses – 200 mg, 300 mg, and 400 mg. All the doses are available in 100's pack.
The price of each tablet of Dexifen® 200 mg is Tk 3. Dexifen® 300 mg tablet will cost Tk 4 and the 400 mg tablet Tk. 5 each.
Soritene® ointment containing 0.1% Tazarotene works against Psoriasis and acne. Soritene® effectively treats psoriasis and can be used for long term due to its better safety profile.
Soritene® is the first tropical retinoid approved by USFDA for treatment of psoriasis. Moreover, Soritene® shows outstanding efficacy in treating acne.
The ointment is available in a 25gm collapsible aluminum tube worth Tk.150.
The fourth Beximco Pharma drug introduced for the first time in Bangladesh is Ovalac®. It is an ideal second generation antiviral drug used to treat infections caused by herpes simplex and varicella-zoster virus.
The drug can also be prescribed as a prophylaxis against cytomegalovirus disease. Ovalac® is a preparation of Valacyclovir and is available at a 10-piece packet costing Tk. 150 for each tablet.
BDNEWS/1903 hrs.